University of Alabama Hospital - Infectious Diseases — Birmingham, Alabama

University of Alabama Hospital - Infectious Diseases is a clinical research site located in Birmingham, Alabama, United States 35249-0001.

Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Alabama Hospital - Infectious Diseases has participated in 8 clinical trials.

Therapeutic areas: Bacterial Vaginosis, Chlamydial Infection, Urethritis.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

Sponsor Feasibility Report

Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama Hospital - Infectious Diseases?

University of Alabama Hospital - Infectious Diseases has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama Hospital - Infectious Diseases conducted?

University of Alabama Hospital - Infectious Diseases has 8 clinical trials on record. Their work covers Bacterial Vaginosis, Chlamydial Infection, Urethritis.

Is University of Alabama Hospital - Infectious Diseases accredited by Crixeo Clinical Trials?

University of Alabama Hospital - Infectious Diseases has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama Hospital - Infectious Diseases?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.